Author

Yasunori Murata

Observed names: MURATA, Yasunori, Y. Murata, Yasunori MURATA

Observed institutions: SHOWA Medical University, Osaka Rosai Hospital, The University of Osaka

OpenAlex ID: A5062052264

Relationship of Circulating Tumor Cells to the Effectiveness of Cytotoxic Chemotherapy in Patients With Metastatic Non-Small-Cell Lung Cancer

2012 · Takashi Hirose, Yasunori Murata, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 64

Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation

2017 · Toshimitsu Yamaoka, Tohru Ohmori, et al. · Molecular Cancer Research · 46

Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer

2016 · Takashi Hirose, Ken-ichi Fujita, et al. · Lung Cancer · 39

Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease.

2012 · Kentaro Okuda, Takashi Hirose, et al. · PubMed · 33

Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

2016 · Toshimitsu Yamaoka, Tohru Ohmori, et al. · Molecular Cancer Therapeutics · 30

PDF

Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer

2011 · Yasunori Murata, Takashi Hirose, et al. · European Journal of Cancer · 11

Fatal rupture of pulmonary artery pseudoaneurysm after thoracic radiation therapy against lung squamous cell carcinoma: A case report and literature review

2020 · Yosuke Fukuda, Tetsuya Homma, et al. · Clinical Case Reports · 8

PDF

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

2010 · Yasunari Oki, Takashi Hirose, et al. · Cancer Chemotherapy and Pharmacology · 8

PDF

Evaluation of the Efficacy and Safety of the Combination of Gemcitabine and Nedaplatin for Elderly Patients with Advanced Non-Small-Cell Lung Cancer

2011 · T. Sugiyama, T. Hirose, et al. · Oncology · 7

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study

2023 · Yasunori Murata, Shigeru Tanzawa, et al. · JTO Clinical and Research Reports · 6

PDF

Beneficial Effect of Early Intervention with Garenoxacin for Bacterial Infection-Induced Acute Exacerbation of Bronchial Asthma and Chronic Obstructive Pulmonary Disease

2019 · Tetsuya Homma, Tomoko Kawahara, et al. · International Archives of Allergy and Immunology · 6

Successful Treatment of Seasonal Influenza A (H3N2) infection-related Hemophagocytic Lymphocytosis in an Elderly Man

2016 · Shintaro SUZUKI, Akihiko TANAKA, et al. · Kansenshogaku zasshi · 4

PDF

Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study

2025 · Shigeru Tanzawa, Hiroshige Yoshioka, et al. · Therapeutic Advances in Medical Oncology · 3

Association of Pharmacokinetics or Pharmacogenomics with Toxicity of Erlotinib in Patients with Recurrent Advanced Non-Small Cell Lung Cancer

2014 · T. Hirose, K. Fujita, et al. · Annals of Oncology · 2

A Case of EGFR Mutation and EML4-ALK Mutation-positive Lung Adenocarcinoma That Transformed to Small-cell Lung Cancer After Chemotherapy

2021 · Yasunori Murata, Akihiro Shiroshita, et al. · Haigan · 1

PDF

[Serious S-1-Induced Lung Injury Diagnosed by Early Lung Biopsy-A Case Report].

2019 · Yumiko Kobayashi, Namiko Taniuchi, et al. · PubMed · 1

Retrospective investigation of the usefulness of GPL-core antibody for diagnosing MAC-PD in patients who had undergone bronchoscopic examination

2015 · Yasunari Kishino, Tsukasa Ohnishi, et al. · 1

Clinical Benefit of 2ND EGFR-TKI Retreatment on Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer

2013 · M. Nakashima, T. Hirose, et al. · Annals of Oncology · 1

PDF

A Case of Recurrent Adenocarcinoma Component Following Treatment of Combined Small-cell Lung Cancer Successfully Treated with Cytotoxic Chemotherapy Combined with Immune Checkpoint Inhibitors

2025 · Koichi Ishida, Tomoaki Ota, et al. · Haigan

PDF

Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study

2025 · Fumihiko Kinoshita, Shigeru Tanzawa, et al. · Therapeutic Advances in Medical Oncology

Table S1 from Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation